Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Homo sapiens | hydroxyprostaglandin dehydrogenase 15-(NAD) | Starlite/ChEMBL | No references |
Species | Potential target | Known druggable target | Length | Alignment span | Identity |
---|---|---|---|---|---|
Plasmodium falciparum | steroid dehydrogenase, putative | hydroxyprostaglandin dehydrogenase 15-(NAD) | 266 aa | 216 aa | 22.2 % |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Trypanosoma brucei | PAB1-binding protein , putative | 0.003 | 0.2768 | 1 |
Echinococcus multilocularis | NADP dependent isocitrate dehydrogenase | 0.0019 | 0.0008 | 0.0008 |
Echinococcus multilocularis | NADP dependent isocitrate dehydrogenase | 0.0019 | 0.0008 | 0.0008 |
Loa Loa (eye worm) | hypothetical protein | 0.0056 | 0.9043 | 0.9043 |
Plasmodium falciparum | ataxin-2 like protein, putative | 0.003 | 0.2768 | 0.3055 |
Echinococcus granulosus | sentrin specific protease 1 | 0.0056 | 0.9043 | 1 |
Toxoplasma gondii | LsmAD domain-containing protein | 0.003 | 0.2768 | 0.3055 |
Schistosoma mansoni | hypothetical protein | 0.0041 | 0.5371 | 0.594 |
Loa Loa (eye worm) | isocitrate dehydrogenase | 0.0019 | 0.0008 | 0.0008 |
Plasmodium falciparum | ataxin-2 like protein, putative | 0.003 | 0.2768 | 0.3055 |
Schistosoma mansoni | family C48 unassigned peptidase (C48 family) | 0.0056 | 0.9043 | 1 |
Trichomonas vaginalis | Clan CE, family C48, Ulp1-like cysteine peptidase | 0.0056 | 0.9043 | 0.5 |
Echinococcus granulosus | NADP dependent isocitrate dehydrogenase | 0.0019 | 0.0008 | 0.0008 |
Schistosoma mansoni | NADP-specific isocitrate dehydrogenase | 0.0019 | 0.0008 | 0.0008 |
Toxoplasma gondii | Ulp1 protease family, C-terminal catalytic domain-containing protein | 0.0056 | 0.9043 | 1 |
Plasmodium vivax | sentrin-specific protease 1, putative | 0.0056 | 0.9043 | 1 |
Loa Loa (eye worm) | pigment dispersing factor receptor c | 0.006 | 1 | 1 |
Echinococcus multilocularis | sentrin specific protease 1 | 0.0056 | 0.9043 | 1 |
Brugia malayi | Ulp1 protease family, C-terminal catalytic domain containing protein | 0.0056 | 0.9043 | 0.9043 |
Brugia malayi | latrophilin 2 splice variant baaae | 0.0041 | 0.5371 | 0.5371 |
Plasmodium falciparum | sentrin-specific protease 1 | 0.0056 | 0.9043 | 1 |
Echinococcus multilocularis | NADP dependent isocitrate dehydrogenase | 0.0019 | 0.0008 | 0.0008 |
Loa Loa (eye worm) | hypothetical protein | 0.0041 | 0.5371 | 0.5371 |
Brugia malayi | isocitrate dehydrogenase | 0.0019 | 0.0008 | 0.0008 |
Schistosoma mansoni | family C48 unassigned peptidase (C48 family) | 0.0056 | 0.9043 | 1 |
Plasmodium vivax | ataxin-2 like protein, putative | 0.003 | 0.2768 | 0.3055 |
Brugia malayi | hypothetical protein | 0.0019 | 0.0147 | 0.0147 |
Trypanosoma cruzi | PAB1-binding protein , putative | 0.003 | 0.2768 | 1 |
Entamoeba histolytica | Ulp1 protease family, C-terminal catalytic domain containing protein | 0.0056 | 0.9043 | 0.5 |
Mycobacterium tuberculosis | Probable isocitrate dehydrogenase [NADP] Icd1 (oxalosuccinate decarboxylase) (IDH) (NADP+-specific ICDH) (IDP) | 0.0019 | 0.0008 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.006 | 1 | 1 |
Echinococcus multilocularis | isocitrate dehydrogenase | 0.0019 | 0.0008 | 0.0008 |
Leishmania major | hypothetical protein, conserved | 0.003 | 0.2768 | 1 |
Trypanosoma cruzi | PAB1-binding protein , putative | 0.003 | 0.2768 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.003 | 0.2768 | 0.2768 |
Brugia malayi | Isocitrate dehydrogenase | 0.0019 | 0.0008 | 0.0008 |
Brugia malayi | hypothetical protein | 0.003 | 0.2768 | 0.2768 |
Echinococcus multilocularis | isocitrate dehydrogenase 2 (NADP+) | 0.0019 | 0.0008 | 0.0008 |
Brugia malayi | Calcitonin receptor-like protein seb-1 | 0.006 | 1 | 1 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
Potency (functional) | = 14.1254 um | PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of HPGD (15-Hydroxyprostaglandin Dehydrogenase). (Class of assay: confirmatory) [Related pubchem assays: 2429 (Confirmation qHTS Assay for Inhibitors of HPGD (15-Hydroxyprostaglandin Dehydrogenase)), 2407 (Probe Development Summary for Inhibitors of HPGD (15-Hydroxyprostaglandin Dehydrogenase)), 2427 (Thermal Shift Assay for Inhibitors of HPGD (15-Hydroxyprostaglandin Dehydrogenase))] | ChEMBL. | No reference |
Potency (functional) | 22.3872 uM | PubChem BioAssay. qHTS for Agonist of gsp, the Etiologic Mutation Responsible for Fibrous Dysplasia/McCune-Albright Syndrome: qHTS. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | = 28.1838 um | PUBCHEM_BIOASSAY: qHTS Assay for Identifying the Cell-Membrane Permeable IMPase Inhibitors: Potentiation with Lithium. (Class of assay: confirmatory) [Related pubchem assays: 901 ] | ChEMBL. | No reference |
Potency (functional) | 89.1251 uM | PUBCHEM_BIOASSAY: HTS for Inhibitors of HP1-beta Chromodomain Interactions with Methylated Histone Tails. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488962] | ChEMBL. | No reference |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.